KR101824829B1 - 피리딜아미노아세트산 화합물을 포함하는 의약 제제 - Google Patents

피리딜아미노아세트산 화합물을 포함하는 의약 제제 Download PDF

Info

Publication number
KR101824829B1
KR101824829B1 KR1020167018735A KR20167018735A KR101824829B1 KR 101824829 B1 KR101824829 B1 KR 101824829B1 KR 1020167018735 A KR1020167018735 A KR 1020167018735A KR 20167018735 A KR20167018735 A KR 20167018735A KR 101824829 B1 KR101824829 B1 KR 101824829B1
Authority
KR
South Korea
Prior art keywords
salt
present
pyridin
glaucoma
pyrazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167018735A
Other languages
English (en)
Korean (ko)
Other versions
KR20160101030A (ko
Inventor
나비드 샴스
헹크 안드레 크룬
히사시 가와타
노리코 가와바타
Original Assignee
산텐 세이야꾸 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53520400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101824829(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 산텐 세이야꾸 가부시키가이샤 filed Critical 산텐 세이야꾸 가부시키가이샤
Publication of KR20160101030A publication Critical patent/KR20160101030A/ko
Application granted granted Critical
Publication of KR101824829B1 publication Critical patent/KR101824829B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • Y10S514/913—

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020167018735A 2014-01-10 2015-01-08 피리딜아미노아세트산 화합물을 포함하는 의약 제제 Active KR101824829B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461925882P 2014-01-10 2014-01-10
US61/925,882 2014-01-10
PCT/JP2015/050366 WO2015105144A1 (ja) 2014-01-10 2015-01-08 ピリジルアミノ酢酸化合物を含む医薬製剤

Publications (2)

Publication Number Publication Date
KR20160101030A KR20160101030A (ko) 2016-08-24
KR101824829B1 true KR101824829B1 (ko) 2018-02-01

Family

ID=53520400

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167018735A Active KR101824829B1 (ko) 2014-01-10 2015-01-08 피리딜아미노아세트산 화합물을 포함하는 의약 제제

Country Status (26)

Country Link
US (9) US9415038B2 (https=)
EP (3) EP3093018B1 (https=)
JP (7) JP5846338B2 (https=)
KR (1) KR101824829B1 (https=)
CN (2) CN108743587B (https=)
AU (1) AU2015205188B2 (https=)
BR (1) BR112016015763B8 (https=)
CA (1) CA2936026C (https=)
CL (1) CL2016001756A1 (https=)
DK (1) DK3093018T3 (https=)
EA (1) EA031734B1 (https=)
ES (2) ES2711091T3 (https=)
GE (2) GEP20186917B (https=)
HK (1) HK1223036A1 (https=)
HU (1) HUE041653T2 (https=)
IL (1) IL246447B (https=)
MX (1) MX370361B (https=)
MY (1) MY163235A (https=)
PH (1) PH12016501357B1 (https=)
PL (1) PL3093018T3 (https=)
PT (1) PT3093018T (https=)
SG (1) SG11201605653RA (https=)
TR (1) TR201902019T4 (https=)
TW (1) TWI598113B (https=)
UA (1) UA117506C2 (https=)
WO (1) WO2015105144A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101858373B1 (ko) * 2014-01-10 2018-05-15 산텐 세이야꾸 가부시키가이샤 피리딜아미노아세트산 화합물과 폴리옥시에틸렌 피마자유를 함유하는 의약 조성물
EP3093018B1 (en) 2014-01-10 2018-11-28 Santen Pharmaceutical Co., Ltd Pharmaceutical preparation including pyridylamino acetic acid compound
CA2935055C (en) 2014-01-10 2021-08-24 Santen Pharmaceutical Co., Ltd. Pharmaceutical composition containing pyridylaminoacetic acid compound
JP5951922B1 (ja) * 2014-12-12 2016-07-13 興和株式会社 水性組成物
CN107708738B (zh) * 2015-07-01 2022-03-25 参天制药株式会社 含有柠檬酸酯的贮库制剂
US20180200239A1 (en) * 2015-07-09 2018-07-19 Santen Pharmaceutical Co., Ltd. Prophylactic and/or therapeutic agent containing pyridylaminoacetic acid compound
US11433090B2 (en) 2017-06-16 2022-09-06 The Doshisha mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof
WO2018230713A1 (ja) 2017-06-16 2018-12-20 学校法人同志社 カスパーゼ阻害活性を有する化合物、これらの化合物を含む、角膜内皮の症状、障害または疾患を治療または予防するための医薬およびその応用
WO2019065838A1 (ja) * 2017-09-29 2019-04-04 参天製薬株式会社 ピリジルアミノ酢酸化合物を含有する医薬
CA3086445A1 (en) 2017-12-21 2019-06-27 Santen Pharmaceutical Co., Ltd. Omidenepag combination
CN111526876A (zh) * 2017-12-28 2020-08-11 参天制药株式会社 含有吡啶基氨基乙酸化合物的药物制剂
PL3681500T3 (pl) * 2018-04-24 2022-08-01 Allergan, Inc. Zastosowanie chlorowodorku pilokarpiny w leczeniu starczowzroczności

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002356420A (ja) * 2001-03-27 2002-12-13 Santen Pharmaceut Co Ltd 安定な水性液剤
WO2009113600A1 (ja) 2008-03-12 2009-09-17 宇部興産株式会社 ピリジルアミノ酢酸化合物
WO2010113957A1 (ja) 2009-03-30 2010-10-07 宇部興産株式会社 緑内障の治療又は予防のための医薬組成物
JP2011057633A (ja) 2009-09-11 2011-03-24 Ube Industries Ltd ピリジルアミノ酢酸化合物を含有する医薬

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120202863A1 (en) * 2011-02-03 2012-08-09 Gerald Horn Compositions and methods for treatment of glaucoma
US20140018350A1 (en) 2012-07-13 2014-01-16 Asahi Glass Co., Ltd. Combination of sulfonamide compound and tafluprost
JP2014019650A (ja) * 2012-07-13 2014-02-03 Santen Pharmaceut Co Ltd スルホンアミド化合物とタフルプロストの組み合わせ
CA3099517C (en) * 2012-07-13 2022-04-26 Santen Pharmaceutical Co., Ltd. Combinations comprising a sulfonamide compound for the treatment of glaucoma or ocular hypertension
US9339496B2 (en) * 2012-07-13 2016-05-17 Santen Pharmaceutical Co., Ltd. Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonist
KR101858373B1 (ko) 2014-01-10 2018-05-15 산텐 세이야꾸 가부시키가이샤 피리딜아미노아세트산 화합물과 폴리옥시에틸렌 피마자유를 함유하는 의약 조성물
EP3093018B1 (en) * 2014-01-10 2018-11-28 Santen Pharmaceutical Co., Ltd Pharmaceutical preparation including pyridylamino acetic acid compound
CA2935055C (en) * 2014-01-10 2021-08-24 Santen Pharmaceutical Co., Ltd. Pharmaceutical composition containing pyridylaminoacetic acid compound

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002356420A (ja) * 2001-03-27 2002-12-13 Santen Pharmaceut Co Ltd 安定な水性液剤
WO2009113600A1 (ja) 2008-03-12 2009-09-17 宇部興産株式会社 ピリジルアミノ酢酸化合物
WO2010113957A1 (ja) 2009-03-30 2010-10-07 宇部興産株式会社 緑内障の治療又は予防のための医薬組成物
JP2011057633A (ja) 2009-09-11 2011-03-24 Ube Industries Ltd ピリジルアミノ酢酸化合物を含有する医薬

Also Published As

Publication number Publication date
US11793798B2 (en) 2023-10-24
CN108743587B (zh) 2021-04-30
EP3093018A1 (en) 2016-11-16
US20150196541A1 (en) 2015-07-16
ES2834334T3 (es) 2021-06-17
EP3424503B1 (en) 2020-09-02
US10179127B2 (en) 2019-01-15
JP2024019479A (ja) 2024-02-09
EP3093018A4 (en) 2017-09-13
CA2936026A1 (en) 2015-07-16
NZ721620A (en) 2021-08-27
JP6491588B2 (ja) 2019-03-27
TW201609186A (zh) 2016-03-16
JP2025142352A (ja) 2025-09-30
ES2711091T3 (es) 2019-04-30
EA031734B1 (ru) 2019-02-28
US9415038B2 (en) 2016-08-16
CL2016001756A1 (es) 2017-05-12
PH12016501357B1 (en) 2020-12-09
GEAP201814239A (en) 2018-07-25
JPWO2015105144A1 (ja) 2017-03-23
JP7726542B2 (ja) 2025-08-20
CN108743587A (zh) 2018-11-06
IL246447A0 (en) 2016-08-31
EP3424503A1 (en) 2019-01-09
TWI598113B (zh) 2017-09-11
US20250235439A1 (en) 2025-07-24
HUE041653T2 (hu) 2019-05-28
US20240000763A1 (en) 2024-01-04
US20190105310A1 (en) 2019-04-11
JP2021006593A (ja) 2021-01-21
US20160324838A1 (en) 2016-11-10
BR112016015763B8 (pt) 2020-09-15
MY163235A (en) 2017-08-30
EA201691402A1 (ru) 2016-10-31
PL3093018T3 (pl) 2019-05-31
US12295946B2 (en) 2025-05-13
MX370361B (es) 2019-12-10
TR201902019T4 (tr) 2019-03-21
CN105899209A (zh) 2016-08-24
HK1223036A1 (zh) 2017-07-21
US20200289483A1 (en) 2020-09-17
JP5846338B2 (ja) 2016-01-20
US20220054466A1 (en) 2022-02-24
KR20160101030A (ko) 2016-08-24
AU2015205188A1 (en) 2016-07-14
GEP20186917B (en) 2018-11-12
MX2016009063A (es) 2016-09-28
SG11201605653RA (en) 2016-08-30
JP7087040B2 (ja) 2022-06-20
EP3750541A1 (en) 2020-12-16
CN105899209B (zh) 2018-09-11
WO2015105144A1 (ja) 2015-07-16
IL246447B (en) 2020-06-30
JP2016027060A (ja) 2016-02-18
JP2022111280A (ja) 2022-07-29
USRE48183E1 (en) 2020-09-01
UA117506C2 (uk) 2018-08-10
AU2015205188B2 (en) 2019-11-14
JP6785330B2 (ja) 2020-11-18
JP2019108363A (ja) 2019-07-04
EP3093018B1 (en) 2018-11-28
US10702511B2 (en) 2020-07-07
BR112016015763B1 (pt) 2020-09-01
PH12016501357A1 (en) 2016-08-15
PT3093018T (pt) 2019-01-10
US20180169079A1 (en) 2018-06-21
US11197849B2 (en) 2021-12-14
DK3093018T3 (en) 2019-02-04
US9943510B2 (en) 2018-04-17
JP7402922B2 (ja) 2023-12-21
CA2936026C (en) 2022-04-19

Similar Documents

Publication Publication Date Title
KR101824829B1 (ko) 피리딜아미노아세트산 화합물을 포함하는 의약 제제
KR101858373B1 (ko) 피리딜아미노아세트산 화합물과 폴리옥시에틸렌 피마자유를 함유하는 의약 조성물
JP2021095406A (ja) ピリジルアミノ酢酸化合物を含有する予防及び／又は治療剤
HK1225280B (en) Pharmaceutical preparation including pyridylamino acetic acid compound
HK1225280A1 (en) Pharmaceutical preparation including pyridylamino acetic acid compound

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
A302 Request for accelerated examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

S17-X000 Non-exclusive voluntary license recorded

St.27 status event code: A-4-4-S10-S17-lic-X000

A101 Application to extend term of patent right by permit
PA0101 Application to register extension of term of patent right by permit, etc.

St.27 status event code: A-4-4-G10-G18-tex-PA0101

Protection beyond ip right term event data comment text: Claim Total Quantity : 13, Claim Number : 1 13, Period Limitation Text : 580, Comment Text : 29

PE0702 Decision to register extension of term of patent right by permit, etc.

St.27 status event code: A-4-4-G10-G20-tex-PE0702

Protection beyond ip right term event data comment text: Claim Total Quantity : 13, Claim Number : 1 13, Period Limitation Text : 580, Comment Text : 29

FPAY Annual fee payment

Payment date: 20210108

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20211215

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 9